Marisol De La Fuente-Granada

Dr. Marisol De La Fuente-Granada

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2012 in Cancer Research
Verified
Journal Article
Closed access
PDF file
Marco Velasco-VelazquezMarco Velasco-Velazquez
Marco Velasco-Velazquez
XJXuanmao Jiao
Xuanmao Jiao
MFMarisol De La Fuente-Granada
Marisol De La Fuente-Granada
TPTimothy G. Pestell
Timothy G. Pestell
AEAdam Ertel
Adam Ertel
RPRichard G. Pestell
Richard G. Pestell
The roles of the chemokine CCL5 and its receptor CCR5 in breast cancer progression remain unclear. Here, we conducted microarray analysis on 2,254 human breast cancer specimens and found increased expression of CCL5 and its receptor CCR5, but not CCR3, in the basal and HER-2 genetic subtypes. The subpopulation of human breast cancer cell lines found to express CCR5 displayed a functional response to CCL5. In addition, oncogene transformation induced CCR5 expression, and the subpopulation of cells that expressed functional CCR5 also displayed increased invasiveness. The CCR5 antagonists maraviroc or vicriviroc, developed to block CCR5 HIV coreceptor function, reduced in vitro invasion of basal breast cancer cells without affecting cell proliferation or viability, and maraviroc decreased pulmonary metastasis in a preclinical mouse model of breast cancer. Taken together, our findings provide evidence for the key role of CCL5/CCR5 in the invasiveness of basal breast cancer cells and suggest that CCR5 antagonists may be used as an adjuvant therapy to reduce the risk of metastasis in patients with the basal breast cancer subtype. Cancer Res; 72(15); 3839–50. ©2012 AACR.

1 April 2012 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
Marco Velasco-VelazquezMarco Velasco-Velazquez
Marco Velasco-Velazquez
NHNora Homsi
Nora Homsi
MFMarisol De La Fuente-Granada
Marisol De La Fuente-Granada
RPRichard G. Pestell
Richard G. Pestell

1 December 2018 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
JGJuan Carlos González-Orozco
Juan Carlos González-Orozco
VHValeria Hansberg-Pastor
Valeria Hansberg-Pastor
PVPaulina Valadez-Cosmes
Paulina Valadez-Cosmes
WNWalter Nicolas-Ortega
Walter Nicolas-Ortega
YBYenifer Bastida-Beristain
Yenifer Bastida-Beristain
ICIgnacio Camacho-Arroyo
Ignacio Camacho-Arroyo

1 December 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SOSandra Ortega-Francisco
Sandra Ortega-Francisco
MFMarisol De La Fuente-Granada
Marisol De La Fuente-Granada
ESEvelyn K. Alvarez Salazar
Evelyn K. Alvarez Salazar
LBLizbeth Airais Bolaños-Castro
Lizbeth Airais Bolaños-Castro
Gabriela Fonseca-CamarilloGabriela Fonseca-Camarillo
Gabriela Fonseca-Camarillo
GSGloria Soldevila
Gloria Soldevila

9 December 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RORoxana Olguín-Alor
Roxana Olguín-Alor
MFMarisol De La Fuente-Granada
Marisol De La Fuente-Granada
LBLaura C. Bonifaz
Laura C. Bonifaz
LALaura Antonio-Herrera
Laura Antonio-Herrera
EGEduardo A. García-Zepeda
Eduardo A. García-Zepeda
GSGloria Soldevila
Gloria Soldevila
Inhibins are members of the TGFβ superfamily, which regulate many cellular processes including differentiation, proliferation, survival and apoptosis. Although initially described as hormones regulating the hypothalamus-pituitary-gonadal axis, based on their ability to antagonize Activins, our group has recently reported that they play a role in thymocyte differentiation and survival, as well as in thymic stromal cell maturation and nTreg generation. Here, we used Inhibin knock out mice (Inhα-/-) to investigate the role of Inhibins in peripheral dendritic cell maturation and function. We first demonstrated that LPS treated Inhα+/+ bone marrow derived dendritic cells (BMDC) were capable to produce significant levels of Inhibin A. Interestingly, Inhα-/- BMDC showed reduced MHCII and CD86 upregulation and increased PD-L1 expression in response to LPS compared to Inhα+/+, which correlated with reduced ability to induce proliferation of allogeneic T cells. The “semi-mature” phenotype displayed by Inhα-/- mBMDC correlated with increased levels of IL-10 and slightly decreased IL-6 production after LPS stimulation. In addition, Inhα-/- mBMDC showed impaired migration towards CCL19 and CCL21, assessed by in vitro chemotaxis and in vivo competitive homing experiments, despite their normal CCR7 expression. Furthermore, in vivo LPS-induced DC maturation was also diminished in Inhα-/- mice, specially within the LC (CD207+ CD11b+ CD103-) subpopulation. Finally, analysis of delayed type hypersensitivity responses in Inhα-/- mice, showed reduced ear swelling as a result of reduced cellular infiltration in the skin, correlating with impaired homing of CD207+ DCs to the draining lymph nodes. In summary, our data demonstrate for the first time that Inhibins play a key role in peripheral DC maturation and function, regulating the balance between immunity and tolerance.

1 May 2019 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
Silvia Valdés-RivesSilvia Valdés-Rives
Silvia Valdés-Rives
MFMarisol De La Fuente-Granada
Marisol De La Fuente-Granada
Marco Velasco-VelazquezMarco Velasco-Velazquez
Marco Velasco-Velazquez
OGOscar González-Flores
Oscar González-Flores
AGAliesha González-Arenas
Aliesha González-Arenas